Home/Lysoway Therapeutics/Valerie Cullen, PhD
VC

Valerie Cullen, PhD

SVP, Head of Research and Translational Sciences

Lysoway Therapeutics

Lysoway Therapeutics Pipeline

DrugIndicationPhase
TRPML1 Agonist ProgramAlzheimer's Disease, Parkinson's Disease, Lysosomal Storage DisordersPre-clinical
TMEM175 Agonist ProgramAlzheimer's Disease, Parkinson's Disease, Lysosomal Storage DisordersPre-clinical